PIBRENTASVIR | PIBRENTASVIR | ATC J05AP57
ANTIINFECTIVES TREATMENT OF HEPATITIS C VIRUS (HCV) NS3/4A PROTEASE INHIBITOR | ORAL | Cmax 98.9 NANOMOLAR Tmax 5 HOUR PPB 99.9 PERCENT HT 13 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | NS5A PROTEASE | Unknown more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |